PDF herunterladen
CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2006; 27(01): 27-29
DOI: 10.1055/s-0041-1733146
Selected Summary

ACVBP Versus CHOP Plus Radiotherapy for Localized Aggressive Lymphoma

Kunjahari Medhi
Department of Medical Oncology, Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi 110029, India
› Institutsangaben
› Weitere Informationen
Auch verfügbar auf
  als PDF herunterladen Lizenzen und Reprints


Publikationsverlauf

Artikel online veröffentlicht:
23. März 2022

© 2006. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics, 2000. CA Cancer J Clin. 2000;50:7-33.
  • 2 Fisher RI, Gaynor ER, Dahlberg S et al. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. N Engl J Med 1993;328:1002-6.
  • 3 Miller TP, LeBlanc M, Spier C, et al. CHOP alone compare to CHOP plus radiotherapy for early state aggressive non- Hodgkin's lymphomas: update of the Southwest Oncology Group (SWOG) randomized trial [abstract]. Blood 2001;98:724a.
  • 4 Horning SJ, Weller E, Kim K et al. Chemotherapy with or without radiotherapy in limited-stage diffuse aggressive non-Hodgkin's lymphoma: Eastern Cooperative Oncology Group study 1484. J Clin Oncol. 2004;22:3032-8.
  • 5 Reyes F, Lepage E et al. Superiority of chemotherapy alone with the ACVBP regimen over treatment with three cycles of CHOP plus radiotherapy in low risk localized aggressive lymphoma: the LNH 93-1 GELA study. Blood 2002;100:93a.
  • 6 Shipp M for The International Non-Hodgkin's Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med. 1993;329:987-994.
  • 7 Reyes, F, Lepage, E, Ganem G, et al. ACVBP versus CHOP plus radiotherapy for localized aggressive lymphoma . N Eng J Med 2005;352 :1197-205.
  • 8 Cheson BD, Horning SJ, Coiffier B et al. Reports of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. J Clin Oncol 1999;17:1244.
  • 9 Coiffer B, Lepage E, Briere J et al.CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-cell lymphoma. N Engl J Med 2002;346:235.